Effects and potential mechanism of atorvastatin treatment on Lp-PLA2 in rats with dyslipidemia.
Conclusions: Atorvastatin treatment is beneficial for reducing the Lp-PLA2 level in rats with dyslipidemia, which may be related to reduced ROCK1 expression in a dose-dependent manner.
PMID: 29765452 [PubMed]
Source: Archives of Medical Science - Category: General Medicine Tags: Arch Med Sci Source Type: research
More News: Atorvastatin Calcium | Biomedical Science | Cholesterol | Diets | General Medicine | High Fat | Lipitor | Nutrition | Science | Statin Therapy | Study | Zivast